Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PREGABALIN, with a corresponding US DMF Number 31415.
Remarkably, this DMF maintains an Active status since its submission on May 06, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 17, 2017, and payment made on April 17, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II